Figure 1: Effects of a 9-Week Treatment With Valsartan on Cardiac Hypertrophy Development Caused by Severe Volume Overload From AR.

doi 10.7717/peerj.7461/fig-1
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

PeerJ

Related search

Figure 3: AR Caused a General Degradation of Diastolic Parameters That Was Improved by Valsartan Treatment in Females but Not in Males.

English

Differential Cardiac Hypertrophy and Signaling Pathways in Pressure Versus Volume Overload.

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2017English

Quercetin Prevents Cardiac Hypertrophy Induced by Pressure Overload in Rats

Journal of Veterinary Medical Science
Veterinary
2009English

Knockout of the ATPase Inhibitory Factor 1 Protects the Heart From Pressure Overload-Induced Cardiac Hypertrophy

Scientific Reports
Multidisciplinary
2017English

Mice Lacking Functional TRPV1 Are Protected From Pressure Overload Cardiac Hypertrophy

Channels
MedicineBiochemistryBiophysics
2011English

Endothelin ETA Receptor Antagonist Blocks Cardiac Hypertrophy Provoked by Hemodynamic Overload

Circulation
Cardiovascular MedicinePhysiologyCardiology
1994English

Analyzing Gene Expression Profiles With Preliminary Validations in Cardiac Hypertrophy Induced by Pressure-Overload

Canadian Journal of Physiology and Pharmacology
MedicinePhysiologyPharmacology
2018English

Targeted Inhibition of Calcineurin in Pressure-Overload Cardiac Hypertrophy

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2002English

Cardiac Hypertrophy in Anion Exchanger 1-Null Mutant Mice With Severe Hemolytic Anemia

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy